The global market for Cefpirome Sulfate for Injection is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Cefpirome Sulfate for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Cefpirome Sulfate for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Cefpirome Sulfate for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Cefpirome Sulfate for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Cefpirome Sulfate for Injection players cover Yangtze River Pharmaceutical Group, Zhejiang JuTai Pharmaceutical, Jiangsu Hengrui Medicine, Henan Kangda Pharmaceutical and QILU Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Cefpirome Sulfate for Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Cefpirome Sulfate for Injection market, with both quantitative and qualitative data, to help readers understand how the Cefpirome Sulfate for Injection market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Cefpirome Sulfate for Injection market and forecasts the market size by Specification (0.25g/Bottle, 0.5g/Bottle and 1.0g/Bottle), by Application (Hospital Pharmacy and Retail Pharmacy.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by specification
0.25g/Bottle
0.5g/Bottle
1.0g/Bottle
Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Yangtze River Pharmaceutical Group
Zhejiang JuTai Pharmaceutical
Jiangsu Hengrui Medicine
Henan Kangda Pharmaceutical
QILU Pharmaceutical
Beijing Sunho Pharmaceutical
Lepu Pharmaceutical
Hainan Weikang Pharmaceutical
Suzhou Dawnrays Pharmaceutical
Shandong Luoxin Pharmaceutical
Guangxi Kelun Pharmaceutical
Haikou Qili Pharmaceutical
Guangzhou Baiyunshan Tianxin Pharmaceutical
Noro Bio-Pharmaceutical
Rex Pharma Group
Cefor
Chapter Introduction
Chapter 1: Scope of Cefpirome Sulfate for Injection, Research Methodology, etc.
Chapter 2: Executive Summary, global Cefpirome Sulfate for Injection market size (sales and revenue) and CAGR, Cefpirome Sulfate for Injection market size by region, by specification, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Cefpirome Sulfate for Injection sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Cefpirome Sulfate for Injection sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by specification, and specification.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Cefpirome Sulfate for Injection market size forecast by region, by country, by specification, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Yangtze River Pharmaceutical Group, Zhejiang JuTai Pharmaceutical, Jiangsu Hengrui Medicine, Henan Kangda Pharmaceutical, QILU Pharmaceutical, Beijing Sunho Pharmaceutical, Lepu Pharmaceutical, Hainan Weikang Pharmaceutical and Suzhou Dawnrays Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cefpirome Sulfate for Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Cefpirome Sulfate for Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Cefpirome Sulfate for Injection by Country/Region, 2017, 2022 & 2028
2.2 Cefpirome Sulfate for Injection Segment by Specification
2.2.1 0.25g/Bottle
2.2.2 0.5g/Bottle
2.2.3 1.0g/Bottle
2.3 Cefpirome Sulfate for Injection Sales by Specification
2.3.1 Global Cefpirome Sulfate for Injection Sales Market Share by Specification (2017-2022)
2.3.2 Global Cefpirome Sulfate for Injection Revenue and Market Share by Specification (2017-2022)
2.3.3 Global Cefpirome Sulfate for Injection Sale Price by Specification (2017-2022)
2.4 Cefpirome Sulfate for Injection Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.5 Cefpirome Sulfate for Injection Sales by Application
2.5.1 Global Cefpirome Sulfate for Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Cefpirome Sulfate for Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Cefpirome Sulfate for Injection Sale Price by Application (2017-2022)
3 Global Cefpirome Sulfate for Injection by Company
3.1 Global Cefpirome Sulfate for Injection Breakdown Data by Company
3.1.1 Global Cefpirome Sulfate for Injection Annual Sales by Company (2020-2022)
3.1.2 Global Cefpirome Sulfate for Injection Sales Market Share by Company (2020-2022)
3.2 Global Cefpirome Sulfate for Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Cefpirome Sulfate for Injection Revenue by Company (2020-2022)
3.2.2 Global Cefpirome Sulfate for Injection Revenue Market Share by Company (2020-2022)
3.3 Global Cefpirome Sulfate for Injection Sale Price by Company
3.4 Key Manufacturers Cefpirome Sulfate for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cefpirome Sulfate for Injection Product Location Distribution
3.4.2 Players Cefpirome Sulfate for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cefpirome Sulfate for Injection by Geographic Region
4.1 World Historic Cefpirome Sulfate for Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Cefpirome Sulfate for Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Cefpirome Sulfate for Injection Annual Revenue by Geographic Region
4.2 World Historic Cefpirome Sulfate for Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Cefpirome Sulfate for Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Cefpirome Sulfate for Injection Annual Revenue by Country/Region
4.3 Americas Cefpirome Sulfate for Injection Sales Growth
4.4 APAC Cefpirome Sulfate for Injection Sales Growth
4.5 Europe Cefpirome Sulfate for Injection Sales Growth
4.6 Middle East & Africa Cefpirome Sulfate for Injection Sales Growth
5 Americas
5.1 Americas Cefpirome Sulfate for Injection Sales by Country
5.1.1 Americas Cefpirome Sulfate for Injection Sales by Country (2017-2022)
5.1.2 Americas Cefpirome Sulfate for Injection Revenue by Country (2017-2022)
5.2 Americas Cefpirome Sulfate for Injection Sales by Specification
5.3 Americas Cefpirome Sulfate for Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cefpirome Sulfate for Injection Sales by Region
6.1.1 APAC Cefpirome Sulfate for Injection Sales by Region (2017-2022)
6.1.2 APAC Cefpirome Sulfate for Injection Revenue by Region (2017-2022)
6.2 APAC Cefpirome Sulfate for Injection Sales by Specification
6.3 APAC Cefpirome Sulfate for Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cefpirome Sulfate for Injection by Country
7.1.1 Europe Cefpirome Sulfate for Injection Sales by Country (2017-2022)
7.1.2 Europe Cefpirome Sulfate for Injection Revenue by Country (2017-2022)
7.2 Europe Cefpirome Sulfate for Injection Sales by Specification
7.3 Europe Cefpirome Sulfate for Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cefpirome Sulfate for Injection by Country
8.1.1 Middle East & Africa Cefpirome Sulfate for Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Cefpirome Sulfate for Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Cefpirome Sulfate for Injection Sales by Specification
8.3 Middle East & Africa Cefpirome Sulfate for Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cefpirome Sulfate for Injection
10.3 Manufacturing Process Analysis of Cefpirome Sulfate for Injection
10.4 Industry Chain Structure of Cefpirome Sulfate for Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cefpirome Sulfate for Injection Distributors
11.3 Cefpirome Sulfate for Injection Customer
12 World Forecast Review for Cefpirome Sulfate for Injection by Geographic Region
12.1 Global Cefpirome Sulfate for Injection Market Size Forecast by Region
12.1.1 Global Cefpirome Sulfate for Injection Forecast by Region (2023-2028)
12.1.2 Global Cefpirome Sulfate for Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cefpirome Sulfate for Injection Forecast by Specification
12.7 Global Cefpirome Sulfate for Injection Forecast by Application
13 Key Players Analysis
13.1 Yangtze River Pharmaceutical Group
13.1.1 Yangtze River Pharmaceutical Group Company Information
13.1.2 Yangtze River Pharmaceutical Group Cefpirome Sulfate for Injection Product Offered
13.1.3 Yangtze River Pharmaceutical Group Cefpirome Sulfate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Yangtze River Pharmaceutical Group Main Business Overview
13.1.5 Yangtze River Pharmaceutical Group Latest Developments
13.2 Zhejiang JuTai Pharmaceutical
13.2.1 Zhejiang JuTai Pharmaceutical Company Information
13.2.2 Zhejiang JuTai Pharmaceutical Cefpirome Sulfate for Injection Product Offered
13.2.3 Zhejiang JuTai Pharmaceutical Cefpirome Sulfate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Zhejiang JuTai Pharmaceutical Main Business Overview
13.2.5 Zhejiang JuTai Pharmaceutical Latest Developments
13.3 Jiangsu Hengrui Medicine
13.3.1 Jiangsu Hengrui Medicine Company Information
13.3.2 Jiangsu Hengrui Medicine Cefpirome Sulfate for Injection Product Offered
13.3.3 Jiangsu Hengrui Medicine Cefpirome Sulfate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Jiangsu Hengrui Medicine Main Business Overview
13.3.5 Jiangsu Hengrui Medicine Latest Developments
13.4 Henan Kangda Pharmaceutical
13.4.1 Henan Kangda Pharmaceutical Company Information
13.4.2 Henan Kangda Pharmaceutical Cefpirome Sulfate for Injection Product Offered
13.4.3 Henan Kangda Pharmaceutical Cefpirome Sulfate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Henan Kangda Pharmaceutical Main Business Overview
13.4.5 Henan Kangda Pharmaceutical Latest Developments
13.5 QILU Pharmaceutical
13.5.1 QILU Pharmaceutical Company Information
13.5.2 QILU Pharmaceutical Cefpirome Sulfate for Injection Product Offered
13.5.3 QILU Pharmaceutical Cefpirome Sulfate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 QILU Pharmaceutical Main Business Overview
13.5.5 QILU Pharmaceutical Latest Developments
13.6 Beijing Sunho Pharmaceutical
13.6.1 Beijing Sunho Pharmaceutical Company Information
13.6.2 Beijing Sunho Pharmaceutical Cefpirome Sulfate for Injection Product Offered
13.6.3 Beijing Sunho Pharmaceutical Cefpirome Sulfate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Beijing Sunho Pharmaceutical Main Business Overview
13.6.5 Beijing Sunho Pharmaceutical Latest Developments
13.7 Lepu Pharmaceutical
13.7.1 Lepu Pharmaceutical Company Information
13.7.2 Lepu Pharmaceutical Cefpirome Sulfate for Injection Product Offered
13.7.3 Lepu Pharmaceutical Cefpirome Sulfate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Lepu Pharmaceutical Main Business Overview
13.7.5 Lepu Pharmaceutical Latest Developments
13.8 Hainan Weikang Pharmaceutical
13.8.1 Hainan Weikang Pharmaceutical Company Information
13.8.2 Hainan Weikang Pharmaceutical Cefpirome Sulfate for Injection Product Offered
13.8.3 Hainan Weikang Pharmaceutical Cefpirome Sulfate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Hainan Weikang Pharmaceutical Main Business Overview
13.8.5 Hainan Weikang Pharmaceutical Latest Developments
13.9 Suzhou Dawnrays Pharmaceutical
13.9.1 Suzhou Dawnrays Pharmaceutical Company Information
13.9.2 Suzhou Dawnrays Pharmaceutical Cefpirome Sulfate for Injection Product Offered
13.9.3 Suzhou Dawnrays Pharmaceutical Cefpirome Sulfate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Suzhou Dawnrays Pharmaceutical Main Business Overview
13.9.5 Suzhou Dawnrays Pharmaceutical Latest Developments
13.10 Shandong Luoxin Pharmaceutical
13.10.1 Shandong Luoxin Pharmaceutical Company Information
13.10.2 Shandong Luoxin Pharmaceutical Cefpirome Sulfate for Injection Product Offered
13.10.3 Shandong Luoxin Pharmaceutical Cefpirome Sulfate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Shandong Luoxin Pharmaceutical Main Business Overview
13.10.5 Shandong Luoxin Pharmaceutical Latest Developments
13.11 Guangxi Kelun Pharmaceutical
13.11.1 Guangxi Kelun Pharmaceutical Company Information
13.11.2 Guangxi Kelun Pharmaceutical Cefpirome Sulfate for Injection Product Offered
13.11.3 Guangxi Kelun Pharmaceutical Cefpirome Sulfate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Guangxi Kelun Pharmaceutical Main Business Overview
13.11.5 Guangxi Kelun Pharmaceutical Latest Developments
13.12 Haikou Qili Pharmaceutical
13.12.1 Haikou Qili Pharmaceutical Company Information
13.12.2 Haikou Qili Pharmaceutical Cefpirome Sulfate for Injection Product Offered
13.12.3 Haikou Qili Pharmaceutical Cefpirome Sulfate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Haikou Qili Pharmaceutical Main Business Overview
13.12.5 Haikou Qili Pharmaceutical Latest Developments
13.13 Guangzhou Baiyunshan Tianxin Pharmaceutical
13.13.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Company Information
13.13.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefpirome Sulfate for Injection Product Offered
13.13.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefpirome Sulfate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Main Business Overview
13.13.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Latest Developments
13.14 Noro Bio-Pharmaceutical
13.14.1 Noro Bio-Pharmaceutical Company Information
13.14.2 Noro Bio-Pharmaceutical Cefpirome Sulfate for Injection Product Offered
13.14.3 Noro Bio-Pharmaceutical Cefpirome Sulfate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Noro Bio-Pharmaceutical Main Business Overview
13.14.5 Noro Bio-Pharmaceutical Latest Developments
13.15 Rex Pharma Group
13.15.1 Rex Pharma Group Company Information
13.15.2 Rex Pharma Group Cefpirome Sulfate for Injection Product Offered
13.15.3 Rex Pharma Group Cefpirome Sulfate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Rex Pharma Group Main Business Overview
13.15.5 Rex Pharma Group Latest Developments
13.16 Cefor
13.16.1 Cefor Company Information
13.16.2 Cefor Cefpirome Sulfate for Injection Product Offered
13.16.3 Cefor Cefpirome Sulfate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Cefor Main Business Overview
13.16.5 Cefor Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Cefpirome Sulfate for Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Cefpirome Sulfate for Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 0.25g/Bottle
Table 4. Major Players of 0.5g/Bottle
Table 5. Major Players of 1.0g/Bottle
Table 6. Global Cefpirome Sulfate for Injection Sales by Specification (2017-2022) & (K Units)
Table 7. Global Cefpirome Sulfate for Injection Sales Market Share by Specification (2017-2022)
Table 8. Global Cefpirome Sulfate for Injection Revenue by Specification (2017-2022) & ($ million)
Table 9. Global Cefpirome Sulfate for Injection Revenue Market Share by Specification (2017-2022)
Table 10. Global Cefpirome Sulfate for Injection Sale Price by Specification (2017-2022) & (US$/Unit)
Table 11. Global Cefpirome Sulfate for Injection Sales by Application (2017-2022) & (K Units)
Table 12. Global Cefpirome Sulfate for Injection Sales Market Share by Application (2017-2022)
Table 13. Global Cefpirome Sulfate for Injection Revenue by Application (2017-2022)
Table 14. Global Cefpirome Sulfate for Injection Revenue Market Share by Application (2017-2022)
Table 15. Global Cefpirome Sulfate for Injection Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Cefpirome Sulfate for Injection Sales by Company (2020-2022) & (K Units)
Table 17. Global Cefpirome Sulfate for Injection Sales Market Share by Company (2020-2022)
Table 18. Global Cefpirome Sulfate for Injection Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Cefpirome Sulfate for Injection Revenue Market Share by Company (2020-2022)
Table 20. Global Cefpirome Sulfate for Injection Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Cefpirome Sulfate for Injection Producing Area Distribution and Sales Area
Table 22. Players Cefpirome Sulfate for Injection Products Offered
Table 23. Cefpirome Sulfate for Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Cefpirome Sulfate for Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Cefpirome Sulfate for Injection Sales Market Share Geographic Region (2017-2022)
Table 28. Global Cefpirome Sulfate for Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Cefpirome Sulfate for Injection Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Cefpirome Sulfate for Injection Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Cefpirome Sulfate for Injection Sales Market Share by Country/Region (2017-2022)
Table 32. Global Cefpirome Sulfate for Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Cefpirome Sulfate for Injection Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Cefpirome Sulfate for Injection Sales by Country (2017-2022) & (K Units)
Table 35. Americas Cefpirome Sulfate for Injection Sales Market Share by Country (2017-2022)
Table 36. Americas Cefpirome Sulfate for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Cefpirome Sulfate for Injection Revenue Market Share by Country (2017-2022)
Table 38. Americas Cefpirome Sulfate for Injection Sales by Type (2017-2022) & (K Units)
Table 39. Americas Cefpirome Sulfate for Injection Sales Market Share by Specification (2017-2022)
Table 40. Americas Cefpirome Sulfate for Injection Sales by Application (2017-2022) & (K Units)
Table 41. Americas Cefpirome Sulfate for Injection Sales Market Share by Application (2017-2022)
Table 42. APAC Cefpirome Sulfate for Injection Sales by Region (2017-2022) & (K Units)
Table 43. APAC Cefpirome Sulfate for Injection Sales Market Share by Region (2017-2022)
Table 44. APAC Cefpirome Sulfate for Injection Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Cefpirome Sulfate for Injection Revenue Market Share by Region (2017-2022)
Table 46. APAC Cefpirome Sulfate for Injection Sales by Specification (2017-2022) & (K Units)
Table 47. APAC Cefpirome Sulfate for Injection Sales Market Share by Specification (2017-2022)
Table 48. APAC Cefpirome Sulfate for Injection Sales by Application (2017-2022) & (K Units)
Table 49. APAC Cefpirome Sulfate for Injection Sales Market Share by Application (2017-2022)
Table 50. Europe Cefpirome Sulfate for Injection Sales by Country (2017-2022) & (K Units)
Table 51. Europe Cefpirome Sulfate for Injection Sales Market Share by Country (2017-2022)
Table 52. Europe Cefpirome Sulfate for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Cefpirome Sulfate for Injection Revenue Market Share by Country (2017-2022)
Table 54. Europe Cefpirome Sulfate for Injection Sales by Type (2017-2022) & (K Units)
Table 55. Europe Cefpirome Sulfate for Injection Sales Market Share by Specification (2017-2022)
Table 56. Europe Cefpirome Sulfate for Injection Sales by Application (2017-2022) & (K Units)
Table 57. Europe Cefpirome Sulfate for Injection Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Cefpirome Sulfate for Injection Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Cefpirome Sulfate for Injection Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Cefpirome Sulfate for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Cefpirome Sulfate for Injection Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Cefpirome Sulfate for Injection Sales by Specification (2017-2022) & (K Units)
Table 63. Middle East & Africa Cefpirome Sulfate for Injection Sales Market Share by Specification (2017-2022)
Table 64. Middle East & Africa Cefpirome Sulfate for Injection Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Cefpirome Sulfate for Injection Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Cefpirome Sulfate for Injection
Table 67. Key Market Challenges & Risks of Cefpirome Sulfate for Injection
Table 68. Key Industry Trends of Cefpirome Sulfate for Injection
Table 69. Cefpirome Sulfate for Injection Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Cefpirome Sulfate for Injection Distributors List
Table 72. Cefpirome Sulfate for Injection Customer List
Table 73. Global Cefpirome Sulfate for Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Cefpirome Sulfate for Injection Sales Market Forecast by Region
Table 75. Global Cefpirome Sulfate for Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Cefpirome Sulfate for Injection Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Cefpirome Sulfate for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Cefpirome Sulfate for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Cefpirome Sulfate for Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Cefpirome Sulfate for Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Cefpirome Sulfate for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Cefpirome Sulfate for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Cefpirome Sulfate for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Cefpirome Sulfate for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Cefpirome Sulfate for Injection Sales Forecast by Specification (2023-2028) & (K Units)
Table 86. Global Cefpirome Sulfate for Injection Sales Market Share Forecast by Specification (2023-2028)
Table 87. Global Cefpirome Sulfate for Injection Revenue Forecast by Specification (2023-2028) & ($ Millions)
Table 88. Global Cefpirome Sulfate for Injection Revenue Market Share Forecast by Specification (2023-2028)
Table 89. Global Cefpirome Sulfate for Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Cefpirome Sulfate for Injection Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Cefpirome Sulfate for Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Cefpirome Sulfate for Injection Revenue Market Share Forecast by Application (2023-2028)
Table 93. Yangtze River Pharmaceutical Group Basic Information, Cefpirome Sulfate for Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Yangtze River Pharmaceutical Group Cefpirome Sulfate for Injection Product Offered
Table 95. Yangtze River Pharmaceutical Group Cefpirome Sulfate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Yangtze River Pharmaceutical Group Main Business
Table 97. Yangtze River Pharmaceutical Group Latest Developments
Table 98. Zhejiang JuTai Pharmaceutical Basic Information, Cefpirome Sulfate for Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Zhejiang JuTai Pharmaceutical Cefpirome Sulfate for Injection Product Offered
Table 100. Zhejiang JuTai Pharmaceutical Cefpirome Sulfate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Zhejiang JuTai Pharmaceutical Main Business
Table 102. Zhejiang JuTai Pharmaceutical Latest Developments
Table 103. Jiangsu Hengrui Medicine Basic Information, Cefpirome Sulfate for Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Jiangsu Hengrui Medicine Cefpirome Sulfate for Injection Product Offered
Table 105. Jiangsu Hengrui Medicine Cefpirome Sulfate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Jiangsu Hengrui Medicine Main Business
Table 107. Jiangsu Hengrui Medicine Latest Developments
Table 108. Henan Kangda Pharmaceutical Basic Information, Cefpirome Sulfate for Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Henan Kangda Pharmaceutical Cefpirome Sulfate for Injection Product Offered
Table 110. Henan Kangda Pharmaceutical Cefpirome Sulfate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Henan Kangda Pharmaceutical Main Business
Table 112. Henan Kangda Pharmaceutical Latest Developments
Table 113. QILU Pharmaceutical Basic Information, Cefpirome Sulfate for Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. QILU Pharmaceutical Cefpirome Sulfate for Injection Product Offered
Table 115. QILU Pharmaceutical Cefpirome Sulfate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. QILU Pharmaceutical Main Business
Table 117. QILU Pharmaceutical Latest Developments
Table 118. Beijing Sunho Pharmaceutical Basic Information, Cefpirome Sulfate for Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Beijing Sunho Pharmaceutical Cefpirome Sulfate for Injection Product Offered
Table 120. Beijing Sunho Pharmaceutical Cefpirome Sulfate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Beijing Sunho Pharmaceutical Main Business
Table 122. Beijing Sunho Pharmaceutical Latest Developments
Table 123. Lepu Pharmaceutical Basic Information, Cefpirome Sulfate for Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Lepu Pharmaceutical Cefpirome Sulfate for Injection Product Offered
Table 125. Lepu Pharmaceutical Cefpirome Sulfate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Lepu Pharmaceutical Main Business
Table 127. Lepu Pharmaceutical Latest Developments
Table 128. Hainan Weikang Pharmaceutical Basic Information, Cefpirome Sulfate for Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Hainan Weikang Pharmaceutical Cefpirome Sulfate for Injection Product Offered
Table 130. Hainan Weikang Pharmaceutical Cefpirome Sulfate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Hainan Weikang Pharmaceutical Main Business
Table 132. Hainan Weikang Pharmaceutical Latest Developments
Table 133. Suzhou Dawnrays Pharmaceutical Basic Information, Cefpirome Sulfate for Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Suzhou Dawnrays Pharmaceutical Cefpirome Sulfate for Injection Product Offered
Table 135. Suzhou Dawnrays Pharmaceutical Cefpirome Sulfate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Suzhou Dawnrays Pharmaceutical Main Business
Table 137. Suzhou Dawnrays Pharmaceutical Latest Developments
Table 138. Shandong Luoxin Pharmaceutical Basic Information, Cefpirome Sulfate for Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Shandong Luoxin Pharmaceutical Cefpirome Sulfate for Injection Product Offered
Table 140. Shandong Luoxin Pharmaceutical Cefpirome Sulfate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Shandong Luoxin Pharmaceutical Main Business
Table 142. Shandong Luoxin Pharmaceutical Latest Developments
Table 143. Guangxi Kelun Pharmaceutical Basic Information, Cefpirome Sulfate for Injection Manufacturing Base, Sales Area and Its Competitors
Table 144. Guangxi Kelun Pharmaceutical Cefpirome Sulfate for Injection Product Offered
Table 145. Guangxi Kelun Pharmaceutical Cefpirome Sulfate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Guangxi Kelun Pharmaceutical Main Business
Table 147. Guangxi Kelun Pharmaceutical Latest Developments
Table 148. Haikou Qili Pharmaceutical Basic Information, Cefpirome Sulfate for Injection Manufacturing Base, Sales Area and Its Competitors
Table 149. Haikou Qili Pharmaceutical Cefpirome Sulfate for Injection Product Offered
Table 150. Haikou Qili Pharmaceutical Cefpirome Sulfate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Haikou Qili Pharmaceutical Main Business
Table 152. Haikou Qili Pharmaceutical Latest Developments
Table 153. Guangzhou Baiyunshan Tianxin Pharmaceutical Basic Information, Cefpirome Sulfate for Injection Manufacturing Base, Sales Area and Its Competitors
Table 154. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefpirome Sulfate for Injection Product Offered
Table 155. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefpirome Sulfate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. Guangzhou Baiyunshan Tianxin Pharmaceutical Main Business
Table 157. Guangzhou Baiyunshan Tianxin Pharmaceutical Latest Developments
Table 158. Noro Bio-Pharmaceutical Basic Information, Cefpirome Sulfate for Injection Manufacturing Base, Sales Area and Its Competitors
Table 159. Noro Bio-Pharmaceutical Cefpirome Sulfate for Injection Product Offered
Table 160. Noro Bio-Pharmaceutical Cefpirome Sulfate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. Noro Bio-Pharmaceutical Main Business
Table 162. Noro Bio-Pharmaceutical Latest Developments
Table 163. Rex Pharma Group Basic Information, Cefpirome Sulfate for Injection Manufacturing Base, Sales Area and Its Competitors
Table 164. Rex Pharma Group Cefpirome Sulfate for Injection Product Offered
Table 165. Rex Pharma Group Cefpirome Sulfate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 166. Rex Pharma Group Main Business
Table 167. Rex Pharma Group Latest Developments
Table 168. Cefor Basic Information, Cefpirome Sulfate for Injection Manufacturing Base, Sales Area and Its Competitors
Table 169. Cefor Cefpirome Sulfate for Injection Product Offered
Table 170. Cefor Cefpirome Sulfate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 171. Cefor Main Business
Table 172. Cefor Latest Developments
List of Figures
Figure 1. Picture of Cefpirome Sulfate for Injection
Figure 2. Cefpirome Sulfate for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cefpirome Sulfate for Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Cefpirome Sulfate for Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Cefpirome Sulfate for Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 0.25g/Bottle
Figure 10. Product Picture of 0.5g/Bottle
Figure 11. Product Picture of 1.0g/Bottle
Figure 12. Global Cefpirome Sulfate for Injection Sales Market Share by Specification in 2021
Figure 13. Global Cefpirome Sulfate for Injection Revenue Market Share by Specification (2017-2022)
Figure 14. Cefpirome Sulfate for Injection Consumed in Hospital Pharmacy
Figure 15. Global Cefpirome Sulfate for Injection Market: Hospital Pharmacy (2017-2022) & (K Units)
Figure 16. Cefpirome Sulfate for Injection Consumed in Retail Pharmacy
Figure 17. Global Cefpirome Sulfate for Injection Market: Retail Pharmacy (2017-2022) & (K Units)
Figure 18. Global Cefpirome Sulfate for Injection Sales Market Share by Application (2017-2022)
Figure 19. Global Cefpirome Sulfate for Injection Revenue Market Share by Application in 2021
Figure 20. Cefpirome Sulfate for Injection Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Cefpirome Sulfate for Injection Revenue Market Share by Company in 2021
Figure 22. Global Cefpirome Sulfate for Injection Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Cefpirome Sulfate for Injection Revenue Market Share by Geographic Region in 2021
Figure 24. Global Cefpirome Sulfate for Injection Sales Market Share by Region (2017-2022)
Figure 25. Global Cefpirome Sulfate for Injection Revenue Market Share by Country/Region in 2021
Figure 26. Americas Cefpirome Sulfate for Injection Sales 2017-2022 (K Units)
Figure 27. Americas Cefpirome Sulfate for Injection Revenue 2017-2022 ($ Millions)
Figure 28. APAC Cefpirome Sulfate for Injection Sales 2017-2022 (K Units)
Figure 29. APAC Cefpirome Sulfate for Injection Revenue 2017-2022 ($ Millions)
Figure 30. Europe Cefpirome Sulfate for Injection Sales 2017-2022 (K Units)
Figure 31. Europe Cefpirome Sulfate for Injection Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Cefpirome Sulfate for Injection Sales 2017-2022 (K Units)
Figure 33. Middle East & Africa Cefpirome Sulfate for Injection Revenue 2017-2022 ($ Millions)
Figure 34. Americas Cefpirome Sulfate for Injection Sales Market Share by Country in 2021
Figure 35. Americas Cefpirome Sulfate for Injection Revenue Market Share by Country in 2021
Figure 36. United States Cefpirome Sulfate for Injection Revenue Growth 2017-20
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)